Dopaminergic Neurons Hub
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Dopaminergic Neurons Hub</th>
</tr>
<tr>
<td class="label">Marker</td>
<td>Function</td>
</tr>
<tr>
<td class="label">TH</td>
<td>Tyrosine hydroxylase</td>
</tr>
<tr>
<td class="label">SLC6A3/DAT</td>
<td>Dopamine transporter</td>
</tr>
<tr>
<td class="label">SLC18A2/VMAT2</td>
<td>Vesicular transporter</td>
</tr>
<tr>
<td class="label">DDC/AADC</td>
<td>Decarboxylase</td>
</tr>
<tr>
<td class="label">ALDH1A1</td>
<td>Aldehyde dehydrogenase</td>
</tr>
<tr>
<td class="label">CALB1/Calbindin</td>
<td>Calcium-binding protein</td>
</tr>
<tr>
<td class="label">OTX2</td>
<td>Transcription factor</td>
</tr>
</table>
Overview
This hub page provides navigation to all dopaminergic neuron types in the NeuroWiki knowledge base. Dopaminergic neurons synthesize and release dopamine, a catecholamine neurotransmitter essential for motor control, reward processing, motivation, cognition, and endocrine regulation. These neurons constitute less than 1% of all brain neurons yet have profound effects on behavior and are critically implicated in multiple neurodegenerative and psychiatric disorders.
Dopaminergic neurons are defined by their expression of the catecholaminergic machinery:
...
Dopaminergic Neurons Hub
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Dopaminergic Neurons Hub</th>
</tr>
<tr>
<td class="label">Marker</td>
<td>Function</td>
</tr>
<tr>
<td class="label">TH</td>
<td>Tyrosine hydroxylase</td>
</tr>
<tr>
<td class="label">SLC6A3/DAT</td>
<td>Dopamine transporter</td>
</tr>
<tr>
<td class="label">SLC18A2/VMAT2</td>
<td>Vesicular transporter</td>
</tr>
<tr>
<td class="label">DDC/AADC</td>
<td>Decarboxylase</td>
</tr>
<tr>
<td class="label">ALDH1A1</td>
<td>Aldehyde dehydrogenase</td>
</tr>
<tr>
<td class="label">CALB1/Calbindin</td>
<td>Calcium-binding protein</td>
</tr>
<tr>
<td class="label">OTX2</td>
<td>Transcription factor</td>
</tr>
</table>
Overview
This hub page provides navigation to all dopaminergic neuron types in the NeuroWiki knowledge base. Dopaminergic neurons synthesize and release dopamine, a catecholamine neurotransmitter essential for motor control, reward processing, motivation, cognition, and endocrine regulation. These neurons constitute less than 1% of all brain neurons yet have profound effects on behavior and are critically implicated in multiple neurodegenerative and psychiatric disorders.
Dopaminergic neurons are defined by their expression of the catecholaminergic machinery:
[@daubner2011]: The rate-limiting enzyme tyrosine hydroxylase (TH) converts tyrosine to L-DOPA
[@nagatsu1989]: Aromatic L-amino acid decarboxylase (AADC) converts L-DOPA to dopamine
[@eiden2011]: The vesicular monoamine transporter (VMAT2) packages dopamine into synaptic vesicles
[@giros1992]: The dopamine transporter (DAT) reuptakes synaptic dopamine for recycling or degradation
[@eisenhofer2004]: Catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO) metabolize dopamine
Mermaid diagram (expand to render)
Dopaminergic Neuron Hierarchy
Mermaid diagram (expand to render)
Major Dopaminergic Populations
Substantia Nigra Pars Compacta (A9)
- Dopaminergic Neurons SNpc — The primary population lost in Parkinson's disease
- SN Pars Reticulata Neurons — GABAergic output nucleus of basal ganglia
Key characteristics:
- High neuromelanin content (visible as pigmented region)
- Autonomous pacemaking at 2-4 Hz
- Calcium-dependent vulnerability
- Dense alpha-synuclein pathology in PD
Ventral Tegmental Area (A10)
- VTA Dopamine Neurons — Reward and motivation circuitry
Key characteristics:
- Heterogeneous population (dopaminergic, GABAergic, glutamatergic)
- Burst firing during reward prediction error
- Target nucleus accumbens, prefrontal cortex, amygdala
- Implicated in addiction and schizophrenia
Hypothalamic Dopamine
- Arcuate Nucleus Dopamine — Tuberoinfundibular pathway
- Zona Incerta Dopamine — A13 group
Functions: Prolactin inhibition, endocrine regulation
Other Populations
- Retinal Dopamine Neurons — Amacrine and interplexiform cells
- Olfactory Bulb Dopamine — Periglomerular cells
- Periaqueductal Gray Dopamine — A11 group
Dopamine Receptor Systems
Dopamine acts through five G protein-coupled receptors organized into two families:
D1-like Receptors (Gs-coupled)
- D1 Receptor (DRD1) — Most abundant, striatum, prefrontal cortex
- D5 Receptor (DRD5) — Hippocampus, hypothalamus
D2-like Receptors (Gi-coupled)
- D2 Receptor (DRD2) — Presynaptic autoreceptor and postsynaptic
- D3 Receptor (DRD3) — Limbic areas, nucleus accumbens
- D4 Receptor (DRD4) — Prefrontal cortex, minimal striatal expression
Disease Relevance
Parkinson's Disease
The selective loss of SNpc dopaminergic neurons is the pathological hallmark of Parkinson's disease:
[@surmeier2017]: Vulnerability factors — Low calbindin expression, high metabolic demand, calcium oscillations, alpha-synuclein aggregation
[@fearnley1991]: Clinical impact — 50-70% cell loss at symptom onset, leading to striatal dopamine depletion
[@obeso2017]: Therapeutic targets — Levodopa replacement, dopamine agonists, MAO-B inhibitors, deep brain stimulation
Schizophrenia
Dysregulated dopaminergic signaling is central to the dopamine hypothesis of schizophrenia:
[@howes2009]: Hyperactivity — Mesolimbic pathway hyperactivity produces positive symptoms
[@howes2013]: Hypofunction — Mesocortical pathway hypofunction contributes to negative/cognitive symptoms
[@kapur2000]: Antipsychotics — D2 receptor antagonism treats positive symptoms
Addiction and Reward Disorders
The mesolimbic dopamine system mediates reward learning and addiction:
[@schultz2016]: Reward prediction — Phasic dopamine signals encode reward prediction errors
[@lscher2015]: Drug-induced plasticity — Cocaine, amphetamine, opioids hijack dopamine signaling
[@everitt2015]: Habit formation — Chronic exposure shifts behavior from goal-directed to habitual
Other Conditions
- ADHD — D4 receptor variants, dopamine dysregulation
- Depression — Mesolimbic hypofunction, anhedonia
- Restless legs syndrome — Iron-dopamine interaction
- Hyperprolactinemia — Disrupted tuberoinfundibular pathway
Molecular Markers
Related Content
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Dopamine Signaling](/mechanisms/dopaminergic-signaling)
- Reward System
- Basal Ganglia Circuits
- [Alpha-synuclein](/proteins/alpha-synuclein)
See Also
- [Dopaminergic Neurons](/cell-types/dopaminergic-neurons)
- [Dopaminergic Neurons SNpc
- SN Pars Reticulata Neurons
- [VTA Dopamine Neurons](/cell-types/vta-dopamine-neurons)
- [Arcuate Nucleus Dopamine](/cell-types/arcuate-nucleus-dopamine)
- Zona Incerta Dopamine
- Retinal Dopamine Neurons
- Olfactory Bulb Dopamine
](/cell-types/dopaminergic-neurons-snpc
--sn-pars-reticulata-neurons
--vta-dopamine-neurons
--arcuate-nucleus-dopamine
--zona-incerta-dopamine
--retinal-dopamine-neurons
--olfactory-bulb-dopamine)## External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
- [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)